Cero Therapeutics Holdings, Inc. SEC filings CERO

Cero Therapeutics Holdings, Inc. has 445 filings in SEC EDGAR's recent list, going back to Jul 8, 2021. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (material agreement). The company's fiscal year ends on December 31.

Cero Therapeutics Holdings, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Apr 21, 2026 Mar 4, 2026
3 Initial insider ownership Apr 21, 2026 Feb 13, 2026
SCHEDULE 13G Ownership over 5% (passive) Mar 12, 2026 —
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
4 Insider transaction Jun 2, 2025 May 30, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
3/A Ownership document May 8, 2025 Oct 1, 2024
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 4, 2025 —
4 Insider transaction Apr 4, 2025 Mar 31, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 7, 2025 Feb 7, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 17, 2024 —
SC 13G Ownership over 5% (passive) Dec 13, 2024 —
4 Insider transaction Dec 13, 2024 Dec 11, 2024
4 Insider transaction Dec 10, 2024 Dec 6, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
4 Insider transaction Dec 4, 2024 Dec 2, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 20, 2024 —
4 Insider transaction Nov 20, 2024 Sep 25, 2024
3 Initial insider ownership Nov 20, 2024 Sep 24, 2024
SC 13G Ownership over 5% (passive) Nov 20, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 14, 2024 Oct 10, 2024
3 Initial insider ownership Nov 14, 2024 Sep 26, 2024
SC 13D Ownership over 5% (active) Oct 30, 2024 —
3 Initial insider ownership Oct 11, 2024 Oct 11, 2024
4 Insider transaction Oct 2, 2024 Sep 25, 2024
4 Insider transaction Oct 2, 2024 Sep 25, 2024
4 Insider transaction Oct 2, 2024 Sep 25, 2024
4 Insider transaction Oct 2, 2024 Oct 1, 2024
4 Insider transaction Oct 2, 2024 Oct 1, 2024
3 Initial insider ownership Oct 2, 2024 Oct 1, 2024
3 Initial insider ownership Oct 2, 2024 Oct 1, 2024
4 Insider transaction Jul 1, 2024 Jun 28, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4/A Filing Mar 11, 2024 Feb 14, 2024
3/A Filing Feb 26, 2024 Feb 14, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 22, 2024 —
4/A Filing Feb 21, 2024 Feb 14, 2024
4/A Filing Feb 21, 2024 Feb 14, 2024
SC 13D/A Amended ownership over 5% (active) Feb 20, 2024 —
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
4 Insider transaction Feb 16, 2024 Feb 14, 2024
3 Initial insider ownership Feb 16, 2024 Feb 14, 2024
3 Initial insider ownership Feb 16, 2024 Feb 14, 2024
3 Initial insider ownership Feb 16, 2024 Feb 14, 2024
3 Initial insider ownership Feb 16, 2024 Feb 14, 2024
3 Initial insider ownership Feb 16, 2024 Feb 14, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G Ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2023 —
SC 13D Ownership over 5% (active) Feb 1, 2023 —
SC 13G/A Amended ownership over 5% (passive) Jan 25, 2023 —
SC 13G Ownership over 5% (passive) May 6, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 11, 2022 —
SC 13G Ownership over 5% (passive) Feb 8, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 3, 2022 —
SC 13G Ownership over 5% (passive) Oct 22, 2021 —
SC 13G Ownership over 5% (passive) Oct 18, 2021 —
SC 13G Ownership over 5% (passive) Oct 18, 2021 —
4 Insider transaction Oct 12, 2021 Oct 8, 2021
4 Insider transaction Oct 12, 2021 Oct 8, 2021
4 Insider transaction Oct 12, 2021 Oct 8, 2021
4 Insider transaction Oct 12, 2021 Oct 8, 2021
4 Insider transaction Oct 12, 2021 Oct 8, 2021
4 Insider transaction Oct 12, 2021 Oct 8, 2021
4 Insider transaction Oct 12, 2021 Oct 8, 2021
4 Insider transaction Oct 12, 2021 Oct 8, 2021
3 Initial insider ownership Oct 5, 2021 Oct 5, 2021
3 Initial insider ownership Oct 5, 2021 Oct 5, 2021
3 Initial insider ownership Oct 5, 2021 Oct 5, 2021
3 Initial insider ownership Oct 5, 2021 Oct 5, 2021
3 Initial insider ownership Oct 5, 2021 Oct 5, 2021
3 Initial insider ownership Oct 5, 2021 Oct 5, 2021
3 Initial insider ownership Oct 5, 2021 Oct 5, 2021
3 Initial insider ownership Oct 5, 2021 Oct 5, 2021

Showing 125 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CERO (OTC), CEROW (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
, Emerging growth company
SEC CIK
1870404
Former names
CERO THERAPEUTICS HOLDINGS, INC. (until Oct 7, 2026); PHOENIX BIOTECH ACQUISITION CORP. (until Feb 14, 2024)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.